Avonex (interferon beta-1a), the new treatment for multiple sclerosis (MS)

June 1996

There's a lot of excitement about Avonex (interferon beta-1a), the new treatment for multiple sclerosis (MS).

Avonex is a beta-interferon...but it's chemically different from the other MS treatment, Betaseron (interferon beta-1b). That might explain some of the differences in their effects.

Both Avonex and Betaseron reduce the frequency of attacks in patients with the relapsing forms of MS.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote